Differential Effects of Fingolimod and Natalizumab on B Cell Repertoires in Multiple Sclerosis Patients

Kowarik, M. C.; Astling, D.; Lepennetier, G.; Ritchie, A.; Hemmer, B.; Owens, G. P.; Bennett, Jeffrey L.

dc.contributor.author	Kowarik, Markus
dc.date.accessioned	2021-04-27T10:26:20Z
dc.date.available	2021-04-27T10:26:20Z
dc.date.issued	2021	de_DE
dc.identifier.issn	1878-7479
dc.identifier.uri	http://hdl.handle.net/10900/114523
dc.language.iso	en	en
dc.publisher	Springer	de_DE
dc.relation.uri	http://dx.doi.org/10.1007/s13311-020-00975-7
dc.subject.ddc	610	de_DE
dc.subject.ddc	570	de_DE
dc.title	Differential Effects of Fingolimod and Natalizumab on B Cell Repertoires in Multiple Sclerosis Patients	de_DE
dc.type	Article	de_DE
utue.kommentar.intern	"Published: 30 November 2020"	de_DE
utue.quellen.id	20210304112512_00493
utue.publikation.seiten	364–377	de_DE
utue.personen.roh	Kowarik, M. C.
utue.personen.roh	Astling, D.
utue.personen.roh	Lepennetier, G.
utue.personen.roh	Ritchie, A.
utue.personen.roh	Hemmer, B.
utue.personen.roh	Owens, G. P.
utue.personen.roh	Bennett, Jeffrey L.
dcterms.isPartOf.ZSTitelID	Neurotherapeutics	de_DE
dcterms.isPartOf.ZS-Volume	18	de_DE
utue.fakultaet	04 Medizinische Fakultät